Coherus Biosciences Reports Third Quarter 2024 Financial Results And Provides Business Update
Net revenue of $70.8 million in Q3 2024 driven by 30% increase in UDENYCA® net revenue, quarter-over-quarter – – UDENYCA labeling and pac ...